Related Experiment Video
Updated: Jun 21, 2025

Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
The Pathobiology of Behavioral Changes in Multiple System Atrophy: An Update
1Institute of Clinical Neurobiology, Alberichgasse 5/13, 1150 Vienna, Austria.
Behavioral disorders like anxiety and apathy are common in multiple system atrophy (MSA). Understanding their mechanisms is crucial for developing biomarkers and treatments for this rare neurodegenerative disease.
Area of Science:
- Neuroscience
- Neurology
- Psychiatry
Background:
- Behavioral disorders are prevalent in multiple system atrophy (MSA), affecting 30-70% of patients.
- These include anxiety, apathy, attention deficits, compulsive behaviors, and REM sleep behavior disorder (RBD).
- These symptoms are early, pervasive, and may influence disease progression in this synucleinopathy.
Purpose of the Study:
- To explore the poorly understood pathophysiological and biochemical mechanisms underlying behavioral disorders in MSA.
- To investigate the neuroimaging correlates of specific behavioral symptoms in MSA.
- To highlight the need for further research into the pathogenesis of these debilitating comorbidities.
Main Methods:
- Review of existing neuroimaging studies linking specific behavioral changes to brain circuit dysfunction.
- Examination of proposed associations between α-synuclein pathology and anxiety in MSA.
- Analysis of the relationship between REM sleep behavior disorder (RBD) and monoaminergic deficits.
Main Results:
- Neuroimaging implicates cortico-limbic changes in anxiety, prefrontal-subcortical dysfunction in apathy/depression, and basal ganglia/orbito-frontal impairment in compulsive behaviors.
- Anxiety is linked to amygdala α-synuclein pathology; RBD to striatal monoaminergic deficits.
- Mechanisms for other behavioral disorders and their links to non-motor dysfunctions remain largely unknown.
Conclusions:
- Behavioral disorders are significant, early features of multiple system atrophy (MSA) with complex underlying mechanisms.
- Current understanding of pathogenesis is limited, particularly regarding biochemical and functional aspects.
- Further neuroimaging and biochemical studies are essential for developing diagnostic biomarkers and effective treatments for MSA-related behavioral symptoms.
More Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...